title: Changes in ocular onchocerciasis four and twelve months after community-based treatment with ivermectin in a holoendemic onchocerciasis focus.
abstract: The impact of ivermectin mass treatment on ocular onchocerciasis was studied in a holoendemic focus of blinding onchocerciasis in Ghana. A cohort of 417 persons, 369 of whom were treated, was followed up at 4 and 12 months after treatment. The mean ocular microfilarial load in the anterior chamber of the eye and in the cornea of treated persons was reduced to less than 20% and 10% of the pretreatment levels respectively at the 4 months follow-up but had increased significantly by 12 months. Lesions of the eye at the advanced stage of development remained stable. There was significant regression of early lesions of the anterior segment of the eye, particularly iridocyclitis, after ivermectin treatment. In view of the substantial increase of ocular microfilarial loads after 12 months, 6-monthly treatment may be indicated in such highly endemic foci. However, long-term observation is needed to give a correct estimate of the full benefit to be derived from mass treatment with ivermectin.
authors.affiliation: Onchocerciasis Control Programme in West Africa, Ouagadougou, Burkina Faso.
authors.forename: K Y
authors.initials: KY
authors.lastname: Dadzie
authors.forename: J
authors.initials: J
authors.lastname: Remme
authors.forename: E S
authors.initials: ES
authors.lastname: Alley
authors.forename: G
authors.initials: G
authors.lastname: de Sole
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000869:Anterior Eye Segment / Q000469:parasitology; D002648:Child; D015331:Cohort Studies; D003153:Community Health Services; D003315:Cornea / Q000469:parasitology; D005500:Follow-Up Studies; D006801:Humans; D007559:Ivermectin / Q000627:therapeutic use*; D008875:Middle Aged; D015827:Onchocerciasis, Ocular / Q000188:drug therapy* / Q000469:parasitology; D013997:Time Factors
chemical_list: D007559:Ivermectin